Signal Peptide Database - Mammalia

 Entry Details
ID   293
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   P98095    (Created: 1995-11-01 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name   FBLN2_HUMAN
Protein Name   Fibulin-2
Gene   FBLN2
Organism Scientific   Homo sapiens
Organism Common   Human
Lineage   Eukaryota
  Metazoa
    Chordata
      Craniata
        Vertebrata
          Euteleostomi
            Mammalia
              Eutheria
                Euarchontoglires
                  Primates
                    Haplorrhini
                      Catarrhini
                        Hominidae
                          Homo
Protein Length [aa]   1184
Protein Mass [Da]   126544
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   27
chain   Fibulin-2      28   1184
disulfide bond      by similarity   445   472
disulfide bond      by similarity   446   479
disulfide bond      by similarity   459   480
disulfide bond      by similarity   489   518
disulfide bond      by similarity   502   519
disulfide bond      by similarity   521   545
disulfide bond      by similarity   522   552
disulfide bond      by similarity   535   553
disulfide bond      by similarity   608   620
disulfide bond      by similarity   616   629
disulfide bond      by similarity   631   644
disulfide bond      by similarity   683   693
disulfide bond      by similarity   689   702
disulfide bond      by similarity   704   717
disulfide bond      by similarity   723   736
disulfide bond      by similarity   730   745
disulfide bond      by similarity   751   762
disulfide bond      by similarity   768   781
disulfide bond      by similarity   775   790
disulfide bond      by similarity   796   808
disulfide bond      by similarity   814   827
disulfide bond      by similarity   821   836
disulfide bond      by similarity   843   856
disulfide bond      by similarity   862   875
disulfide bond      by similarity   869   884
disulfide bond      by similarity   886   899
disulfide bond      by similarity   905   917
disulfide bond      by similarity   913   926
disulfide bond      by similarity   928   941
disulfide bond      by similarity   947   956
disulfide bond      by similarity   952   965
disulfide bond      by similarity   967   980
disulfide bond      by similarity   986   998
disulfide bond      by similarity   994   1007
disulfide bond      by similarity   1009   1023
disulfide bond      by similarity   1029   1042
disulfide bond      by similarity   1036   1051
disulfide bond      by similarity   1056   1068
domain   Anaphylatoxin-like 1      445   480
domain   Anaphylatoxin-like 2      488   519
domain   Anaphylatoxin-like 3      521   553
domain   EGF-like 1; calcium-binding      604   645
domain   EGF-like 2      679   718
domain   EGF-like 3; calcium-binding      719   763
domain   EGF-like 4; calcium-binding      764   809
domain   EGF-like 5; calcium-binding      810   857
domain   EGF-like 6; calcium-binding      858   900
domain   EGF-like 7; calcium-binding      901   942
domain   EGF-like 8; calcium-binding      943   981
domain   EGF-like 9; calcium-binding      982   1024
domain   EGF-like 10; calcium-binding      1025   1069
region of interest   Subdomain NA (Cys-rich)      28   177
region of interest   N      28   444
region of interest   Subdomain NB (Cys-free)      178   444
region of interest   Domain III      1070   1184
modified residue   Phosphoserine      277   277
glycosylation site   N-linked (GlcNAc...)   potential   180   180
glycosylation site   N-linked (GlcNAc...)   potential   507   507
glycosylation site   N-linked (GlcNAc...)   potential   1035   1035
SP Length   27
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MVLLWEPAGAWLALGLALALGPSVAAA
Sequence MVLLWEPAGAWLALGLALALGPSVAAAAPRQDCTGVECPPLENCIEEALE
PGACCATCVQQGCACEGYQYYDCLQGGFVRGRVPAGQSYFVDFGSTECSC
PPGGGKISCQFMLCPELPPNCIEAVVVADSCPQCGQVGCVHAGHEYAAGH
TVHLPPCRACHCPDAGGELICYQLPGC
HGNFSDAEEGDPERHYEDPYSYD
QEVAEVEAATALGGEVQAGAVQAGAGGPPAALGGGSQPLSTIQAPPWPAV
LPRPTAAAALGPPAPVQAKARRVTED
SEEEEEEEEEREEMAVTEQLAAGG
HRGLDGLPTTAPAGPSLPIQEERAEAGARAEAGARPEENLILDAQATSRS
TGPEGVTHAPSLGKAALVPTQAVPGSPRDPVKPSPHNILSTSLPDAAWIP
PTREVPRKPQVLPHSHVEEDTDPNSVHSIPRSSPEGSTKDLIET
CCAAGQ
QWAIDNDECLEIPESGTEDNVCRTAQRHCC
VSYLQEKSCMAGVLGAKEGE
TCGAED
NDSCGISLYKQCCDCCGLGLRVRAEGQSCESNPNLGYPCNHVML
SCC
EGEEPLIVPEVRRPPEPAAAPRRVSEAEMAGREALSLGTEAELPNSL
PGD
DQDECLLLPGELCQHLCINTVGSYHCACFPGFSLQDDGRTCRPEGHP
PQPEAPQEPALKSEFSQVASNTIPLPLP
QPNTCKDNGPCKQVCSTVGGSA
ICSCFPGYAIMADGVSCE
DINECVTDLHTCSRGEHCVNTLGSFHCYKALT
CEPGYALKDGECE
DVDECAMGTHTCQPGFLCQNTKGSFYCQARQRCMDGF
LQDPEGNCV
DINECTSLSEPCRPGFSCINTVGSYTCQRNPLICARGYHAS
DDGAKCV
DVNECETGVHRCGEGQVCHNLPGSYRCDCKAGFQRDAFGRGCI
DVNECWASPGRLCQHTCENTLGSYRCSCASGFLLAADGKRCEDVNECEAQ
RCSQECANIYGSYQCYCRQGYQLAEDGHTCT
DIDECAQGAGILCTFRCLN
VPGSYQCACPEQGYTMTANGRSCK
DVDECALGTHNCSEAETCHNIQGSFR
CLRFECPPNYVQVSKTKCE
RTTCHDFLECQNSPARITHYQLNFQTGLLVP
AHIFRIGPAPAFTGDTIALNIIKGNEEGYFGTRRLNAYTGVVYLQRAVLE
PRDFALDVEMKLWRQGSVTTFLAKMHIFFTTFAL
Original MVLLWEPAGAWLALGLALALGPSVAAAAPRQDCTGVECPPLENCIEEALE
PGACCATCVQQGCACEGYQYYDCLQGGFVRGRVPAGQSYFVDFGSTECSC
PPGGGKISCQFMLCPELPPNCIEAVVVADSCPQCGQVGCVHAGHEYAAGH
TVHLPPCRACHCPDAGGELICYQLPGCHGNFSDAEEGDPERHYEDPYSYD
QEVAEVEAATALGGEVQAGAVQAGAGGPPAALGGGSQPLSTIQAPPWPAV
LPRPTAAAALGPPAPVQAKARRVTEDSEEEEEEEEEREEMAVTEQLAAGG
HRGLDGLPTTAPAGPSLPIQEERAEAGARAEAGARPEENLILDAQATSRS
TGPEGVTHAPSLGKAALVPTQAVPGSPRDPVKPSPHNILSTSLPDAAWIP
PTREVPRKPQVLPHSHVEEDTDPNSVHSIPRSSPEGSTKDLIETCCAAGQ
QWAIDNDECLEIPESGTEDNVCRTAQRHCCVSYLQEKSCMAGVLGAKEGE
TCGAEDNDSCGISLYKQCCDCCGLGLRVRAEGQSCESNPNLGYPCNHVML
SCCEGEEPLIVPEVRRPPEPAAAPRRVSEAEMAGREALSLGTEAELPNSL
PGDDQDECLLLPGELCQHLCINTVGSYHCACFPGFSLQDDGRTCRPEGHP
PQPEAPQEPALKSEFSQVASNTIPLPLPQPNTCKDNGPCKQVCSTVGGSA
ICSCFPGYAIMADGVSCEDINECVTDLHTCSRGEHCVNTLGSFHCYKALT
CEPGYALKDGECEDVDECAMGTHTCQPGFLCQNTKGSFYCQARQRCMDGF
LQDPEGNCVDINECTSLSEPCRPGFSCINTVGSYTCQRNPLICARGYHAS
DDGAKCVDVNECETGVHRCGEGQVCHNLPGSYRCDCKAGFQRDAFGRGCI
DVNECWASPGRLCQHTCENTLGSYRCSCASGFLLAADGKRCEDVNECEAQ
RCSQECANIYGSYQCYCRQGYQLAEDGHTCTDIDECAQGAGILCTFRCLN
VPGSYQCACPEQGYTMTANGRSCKDVDECALGTHNCSEAETCHNIQGSFR
CLRFECPPNYVQVSKTKCERTTCHDFLECQNSPARITHYQLNFQTGLLVP
AHIFRIGPAPAFTGDTIALNIIKGNEEGYFGTRRLNAYTGVVYLQRAVLE
PRDFALDVEMKLWRQGSVTTFLAKMHIFFTTFAL
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11